MARK MCGOVERN, RN
Rare Disease / Clinical Research
Eidos Therapeutics, a BridgeBio company
PI on 1 trial
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
Clinical trials (1)
Verify independently
Other specialists for Wild type ATTR amyloidosis
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Mazen Hanna, MD, M.DThe Cleveland ClinicOH
- Adalgisa Condoluci, MDOncology Institute of Southern Switzerland
- Mathew S Maurer, MDColumbia University
- John L Berk, M.D., D.D.SBoston UniversityCA
- Nicolas Verheyen, Res Prof, MD PhDMedical University of Graz
- Torstein Hole, MD, PhDHelse Møre og Romsdal HF and NTNU
- Jeff Packman, MBAFoldRx Pharmaceuticals, Inc
- Thibaud DAMY, MD PhDCHU Henri Mondor, Paris